ANNOVIS BIO INC's ticker is ANVS and the CUSIP is 03615A108. A total of 30 filers reported holding ANNOVIS BIO INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $251,000 | – | 7,908 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 463,797 | $3,497,000 | 1.42% |
| Worth Venture Partners, LLC | 119,538 | $901,000 | 0.71% |
| Lokken Investment Group LLC | 32,211 | $243,000 | 0.22% |
| Sterling Investment Advisors, Ltd. | 50,588 | $381,000 | 0.13% |
| Modera Wealth Management, LLC | 43,846 | $331,000 | 0.03% |
| Cannell & Co. | 10,000 | $75,000 | 0.00% |
| Sowell Financial Services LLC | 1,529 | $12,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| MORGAN STANLEY | 14,286 | $108,000 | 0.00% |
| BROWN ADVISORY INC | 14,942 | $113,000 | 0.00% |